Validation of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in ANA-positive Chinese patients

Validation of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in ANA-positive Chinese patients

Background: The aim of this study was to validate the 2019 European League Against Rheumatism/American College of Rheumatology (EULAR/ACR) classification criteria for systemic lupus erythematosus (SLE) in antinuclear antibody (ANA)-positive Chinese patients. Methods: Medical records of all adult pat...

Full description

Bibliographic Details
Main Authors:	Yuen Kwan Chung, Ling Yin Ho, Carolyn Lee, Chi Hung To, Chi Chiu Mok
Format:	Article
Language:	English
Published:	SAGE Publishing 2022-05-01
Series:	Therapeutic Advances in Musculoskeletal Disease
Online Access:	https://doi.org/10.1177/1759720X221100300

Similar Items

LO-010 Relationship between the EULAR/ACR classification criteria and organ damage in systemic lupus erythematosus
by: Ling Yin Ho, et al.
Published: (2023-07-01)

Validation of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in an academic tertiary care centre
by: Arndt Weinmann, et al.
Published: (2023-07-01)

Utility of the ACR-1997, SLICC-2012 and EULAR/ACR-2019 classification criteria for systemic lupus erythematosus: a single-centre retrospective study
by: Leixi Xue, et al.
Published: (2022-07-01)

Prevalence of Sjögren's syndrome according to 2016 ACR-EULAR classification criteria in patients with systemic lupus erythematosus
by: Ana Paula Espíndula Gianordoli, et al.
Published: (2023-03-01)

GOUT CLASSIFICATION CRITERIA (ACR/EULAR GUIDELINES)
by: M. S. Eliseev
Published: (2016-02-01)

Assessment of EULAR/ACR-2019, SLICC-2012 and ACR-1997 Classification Criteria in SLE with Longstanding Disease
by: Berta Magallares, et al.
Published: (2021-05-01)

Evaluating performance of the 2019 EULAR/ACR, 2012 SLICC, and 1997 ACR criteria for classifying adult-onset and childhood-onset systemic lupus erythematosus: A systematic review and meta-analysis
by: Butsabong Lerkvaleekul, et al.
Published: (2022-12-01)

NEW GOUT CLASSIFICATION CRITERIA (ACR/EULAR 2015)
by: N. T. Vatutin, et al.
Published: (2016-08-01)

07 New (ACR/EULAR) antiphospholipid syndrome classification criteria
by: Doruk Erkan
Published: (2023-09-01)

Comparing new diagnostic criteria of 2010 ACR/EULAR with 1987 ACR criteria in rheumatoid arthritis
by: Fatemeh Shirani, et al.
Published: (2017-01-01)

ACR/EULAR-endorsed study to develop Diagnostic and Classification Criteria for Vasculitis (DCVAS).
by: Craven, A, et al.
Published: (2013)

I12 EULAR/ACR SLE classification criteria: 5 years later
by: Martin Aringer
Published: (2024-03-01)

Herpes zoster vaccination in systemic lupus erythematosus: the current status
by: Chi Chiu Mok
Published: (2019-01-01)

Real world experience of the new ACR-EULAR classification criteria for IgG4-related disease
by: Peters, R, et al.
Published: (2021)

Disease Activity Indices in Systemic Lupus Erythematosus: What Is New?
by: Fung Lam, et al.
Published: (2023-12-01)

The new 2019 American college of rheumatology (ACR)/European League Against Rheumatism (EULAR) classification criteria for IgG4-related disease
by: E. V. Sokol
Published: (2020-09-01)

Diagnosis and Management of Catastrophic Antiphospholipid Syndrome and the Potential Impact of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria
by: Lucas Jacobs, et al.
Published: (2024-03-01)

New ACR/EULAR 2010 classification criteria for rheumatoid arthritis: a step forward in its early diagnosis
by: Dmitriy Evgen'evich Karateev, et al.
Published: (2011-02-01)

Measuring treatment outcomes and change in disease activity in giant cell arteritis: a systematic literature review informing the development of the EULAR-ACR response criteria on behalf of the EULAR-ACR response criteria in giant cell arteritis task force
by: Sofia Ramiro, et al.
Published: (2023-06-01)

Application of the 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease in a seronegative rheumatoid arthritis cohort
by: Cesar Díaz-Torné, et al.
Published: (2024-04-01)

REVIEW OF RECOMMENDATIONS FOR THE MANAGEMENT OF POLYMYALGIA RHEUMATICA (ACR/EULAR 2015)
by: M. T. Vatutin, et al.
Published: (2016-03-01)

Symposium 6 <subtitle>Biological Therapies for Systemic Lupus Erythematosus: Something Old, Something New</subtitle>
by: Chi Chiu MOK
Published: (2023-11-01)

According to the 2019 updated European League Against Rheumatism (EULAR) recommendations for the treatment of systemic lupus erythematosus: debatable issues and comments
by: T. V. Popkova, et al.
Published: (2019-11-01)

Nomenclature and classification of vasculitis - update on the ACR/EULAR diagnosis and classification of vasculitis study (DCVAS).
by: Luqmani, R, et al.
Published: (2011)

Differential sensitivity of the 2020 revised comprehensive diagnostic criteria and the 2019 ACR/EULAR classification criteria across IgG4-related disease phenotypes: results from a Norwegian cohort
by: Jens Vikse, et al.
Published: (2023-09-01)

Salivary anti-nuclear antibody (ANA) mirrors serum ANA in systemic lupus erythematosus
by: Ting Zhang, et al.
Published: (2022-01-01)

External validation of the 2022 ACR/EULAR classification criteria in patients with suspected giant cell arteritis in a Dutch fast-track clinic
by: Elisabeth Brouwer, et al.
Published: (2023-08-01)

Vasculitis distribution and clinical characteristics in giant cell arteritis: a retrospective study using the new 2022 ACR/EULAR classification criteria
by: Peter M. Andel, et al.
Published: (2023-11-01)

LP-064 Effect of osteoporosis on major adverse cardiovascular events (MACEs) in systemic lupus erythematosus (SLE): a longitudinal study
by: Ling Yin Ho, et al.
Published: (2023-07-01)

MODERN VIEW OF CARDIOPULMONARY EXERCISE TESTING (REVIEW OF ACR/EULAR GUIDELINES, 2016)
by: N. T. Vatutin, et al.
Published: (2017-03-01)

Performance of the 2022 ACR/EULAR giant cell arteritis classification criteria for diagnosis in patients with suspected giant cell arteritis in routine clinical care
by: Eugenio De Miguel, et al.
Published: (2023-04-01)

LP-065 Prevalence and risk factors of fragility fractures in systemic lupus erythematosus (SLE): a longitudinal study over 12 years
by: Ling Yin Ho, et al.
Published: (2023-07-01)

Systematic literature review informing the EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis
by: Tanja A Stamm, et al.
Published: (2023-07-01)

DEFINITION OF THE TERM «RHEUMATOLOGY»: DO WE NEED THIS AND HOW DO THE EULAR AND THE ACR LOOK AT THIS?
by: Sh. F. Erdes
Published: (2018-07-01)

Anti-Sm antibodies in the classification criteria of systemic lupus erythematosus
by: Joyce J.B.C. van Beers, et al.
Published: (2022-01-01)

Comparison of ACR 1990 and ACR 2010 classification criteria in fibromyalgia syndrome
by: Mustafa Gur, et al.
Published: (2019-12-01)

Predictors of chronicity and the discriminative value of the new ACR/EULAR rheumatoid arthritis classification criteria in an untreated polyarthritis cohort with less than 6 weeks of disease duration
by: Resende C, et al.
Published: (2010-11-01)

Diagnostic accuracy of the European League against rheumatism/American College of Rheumatology-2019 versus the Systemic Lupus International Collaborating Clinics-2012 versus the ACR-1997 classification criteria in adult systemic lupus erythematosus: A systematic review and meta-analysis
by: Wentian Lu, et al.
Published: (2022-10-01)

Overlap Syndrome Consisting of Polymyositis/Dermatomyositis and ANCA-Associated Vasculitis According to the 2022 ACR/EULAR Criteria for Vasculitis: A Korean Single-Centre Study
by: Jang Woo Ha, et al.
Published: (2023-10-01)

AN OVERVIEW OF THE VI EULAR SCIENTIFIC EDUCATIONAL COURSE DEDICATED TO SYSTEMIC LUPUS ERYTHEMATOSUS (PISA, ITALY, SEPTEMBER 1–6, 2013)
by: T. A. Panafidina
Published: (2014-06-01)